ADVERTISEMENT
2 /3 FREE ARTICLES LEFT THIS MONTH Remaining
Chemistry matters. Join us to get the news you need.

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

Drug Development

Cambrex opens new labs in Karlskoga

by Rick Mullin
June 9, 2019 | APPEARED IN VOLUME 97, ISSUE 23

 

09723-buscon17-karlskogacxd.jpg
Credit: Cambrex
Cambrex's active pharmaceutical ingredient plant in Karlskoga, Sweden

Cambrex has completed construction of a 600 m2 facility at its Karlskoga, Sweden, site that incorporates process technology, quality control, and analytical development laboratories. The process technology section will accommodate R&D and production teams working together on scale-up demonstrations for highly potent molecules. The laboratory also includes high-pressure reaction vessels and crystallization equipment.

X

Article:

This article has been sent to the following recipient:

Leave A Comment

*Required to comment